36-Month Outcomes from the Prospective GEMINI Study: Canaloplasty and Trabeculotomy Combined with Cataract Surgery for Patients with Primary Open-Angle Glaucoma

References

• Yang SA, Mitchell W, Hall N., et al. Trends and usage patterns of minimally invasive glaucoma surgery in the United States: IRIS® registry analysis 2013–2018. Ophthalmol Glaucoma. 2021;4(6):558–568. doi:10.1016/j.ogla.2021.03.012
   PubMedGoogle Scholar
• Bicket AK, Le JT, Azuara-Blanco A, et al. Minimally invasive glaucoma surgical techniques for open-angle glaucoma: an overview of cochrane systematic reviews and network meta-analysis. JAMA Ophthalmol. 2021;139(9):983–989. doi:10.1001/jamaophthalmol.2021.2351
   PubMed Web of Science ®Google Scholar
• Birnbaum FA, Neeson C, Solá-Del Valle D. Microinvasive glaucoma surgery: an evidence-based review. Semin Ophthalmol. 2021;36(8):772–786. doi:10.1080/08820538.2021.1903513
   PubMed Web of Science ®Google Scholar
• Gallardo MJ, Pyfer MF, Vold SD, et al. Canaloplasty and trabeculotomy combined with phacoemulsification for glaucoma: 12-month results of the GEMINI study. Clin Ophthalmol. 2022;16:1225–1234. doi:10.2147/OPTH.S362932
   PubMed Web of Science ®Google Scholar
• Samuelson TW, Sarkisian SR, Lubeck DM, et al. Prospective, randomized, controlled pivotal trial of an ab interno implanted trabecular micro-bypass in primary open-angle glaucoma and cataract: two-year results. Ophthalmology. 2019;126(6):811–821. doi:10.1016/j.ophtha.2019.03.006
   PubMed Web of Science ®Google Scholar
• Samuelson TW, Chang DF, Marquis R, et al. A schlemm canal microstent for intraocular pressure reduction in primary open-angle glaucoma and cataract: the HORIZON Study. Ophthalmology. 2019;126(1):29–37. doi:10.1016/j.ophtha.2018.05.012
   PubMed Web of Science ®Google Scholar
• Gallardo MJ, Sarkisian Jr SR, Vold SD, et al. Canaloplasty and trabeculotomy combined with phacoemulsification in open-angle glaucoma: interim results from the GEMINI study. Clin Ophthalmol. 2021;15:481–489. doi:10.2147/OPTH.S296740
   PubMed Web of Science ®Google Scholar
• Pyfer MF, Campbell A, Flowers BE, Dickerson JE, Talla A, Dhamdhere K. Suppression of diurnal (9AM–4PM) IOP fluctuations with minimally invasive glaucoma surgery: an analysis of data from the prospective, multicenter, single-arm GEMINI study. Clin Ophthalmol.2021;15:3931–3938. doi:10.2147/OPTH.S335486
   PubMed Web of Science ®Google Scholar
• Reiss G, Clifford B, Vold S, et al. Safety and effectiveness of CyPass supraciliary micro-stent in primary open-angle glaucoma: 5-year results from the COMPASS XT study. Am J Ophthalmol. 2019;208:219–225. doi:10.1016/j.ajo.2019.07.015
   PubMed Web of Science ®Google Scholar
• Lass JH, Benetz BA, He J, et al. Corneal endothelial cell loss and morphometric changes 5 years after phacoemulsification with or without CyPass micro-stent. Am J Ophthalmol. 2019;208:211–218. doi:10.1016/j.ajo.2019.07.016
   PubMed Web of Science ®Google Scholar
• Ahmed IIK, De Francesco T, Rhee D, et al. Long-term outcomes from the HORIZON randomized trial for a schlemm’s canal microstent in combination cataract and glaucoma surgery. Ophthalmology. 2022;129(7):742–751. doi:10.1016/j.ophtha.2022.02.021
   PubMed Web of Science ®Google Scholar
• Williamson BK, Vold SD, Campbell A, et al. Canaloplasty and trabeculotomy with the OMNI system in patients with open-angle glaucoma: two-year results from the ROMEO Study. Clin Ophthalmol. 2023;17:1057–1066. doi:10.2147/OPTH.S407918
   PubMed Web of Science ®Google Scholar
• Klabe K, Kaymak H. Standalone trabeculotomy and viscodilation of schlemm’s canal and collector channels in open-angle glaucoma using the OMNI surgical system: 24-month outcomes. Clin Ophthalmol. 2021;15:3121–3129. doi:10.2147/OPTH.S325394
   PubMed Web of Science ®Google Scholar
• Ondrejka S, Körber N, Dhamdhere K. Long term effect of canaloplasty on IOP and use of IOP-lowering medications in patients with open angle glaucoma: canaloplasty and IOP/Medications in open angle glaucoma. J Cataract Refract Surg. 2022;48(12):1388–1393. doi:10.1097/j.jcrs.0000000000001000
   PubMed Web of Science ®Google Scholar
• Dickerson JE, Dhamdhere K. Combined circumferential canaloplasty and trabeculotomy ab interno with the OMNI surgical system. Front Ophthalmol. 2021;1(2):106–114.
   Google Scholar
• Yadgarov A, Dentice K, Aljabi Q. Real-world outcomes of canaloplasty and trabeculotomy combined with cataract surgery in eyes with all stages of open-angle glaucoma. Clin Ophthalmol. 2023;17:2609–2617. doi:10.2147/OPTH.S422132
   PubMed Web of Science ®Google Scholar
• Terveen DC, Sarkisian SR, Vold SD, et al. Canaloplasty and trabeculotomy with the OMNI(®) surgical system in OAG with prior trabecular microbypass stenting. Int Ophthalmol. 2022;43(5):1647–1656. doi:10.1007/s10792-022-02553-6
   PubMed Web of Science ®Google Scholar
• Hirsch L, Cotliar J, Vold S, et al. Canaloplasty and trabeculotomy ab interno with the OMNI system combined with cataract surgery in open-angle glaucoma: 12-month outcomes from the ROMEO study. J Cataract Refract Surg. 2021;47(7):907–915. doi:10.1097/j.jcrs.0000000000000552
   PubMed Web of Science ®Google Scholar
• Vold SD, Williamson BK, Hirsch L, et al. Canaloplasty and trabeculotomy with the OMNI system in pseudophakic patients with open-angle glaucoma: the ROMEO study. Ophthalmol Glaucoma. 2021;4(2):173–181. doi:10.1016/j.ogla.2020.10.001
   PubMedGoogle Scholar
• Pfeiffer N, Garcia-Feijoo J, Martinez-de-la-Casa JM, et al. A randomized trial of a schlemm’s canal microstent with phacoemulsification for reducing intraocular pressure in open-angle glaucoma. Ophthalmology. 2015;122(7):1283–1293. doi:10.1016/j.ophtha.2015.03.031
   PubMed Web of Science ®Google Scholar
• Hengerer FH, Auffarth GU, Riffel C, Conrad-Hengerer I. Second-generation trabecular micro-bypass stents as standalone treatment for glaucoma: a 36-month prospective study. Adv Ther. 2019;36(7):1606–1617. doi:10.1007/s12325-019-00984-9
   PubMed Web of Science ®Google Scholar
• Clement C, Howes F, Ioannidis A, et al. Multicenter effectiveness and disease stability through 3 years after istenttrabecular micro-bypass with phacoemulsification in glaucoma and ocular hypertension. Clin Ophthalmol. 2022;16:2955–2968. doi:10.2147/OPTH.S373290
   PubMed Web of Science ®Google Scholar
• Lindstrom R, Sarkisian SR, Lewis R, Hovanesian J, Voskanyan L. Four-year outcomes of two second-generation trabecular micro-bypass stents in patients with open-angle glaucoma on one medication. Clin Ophthalmol. 2020;14:71–80. doi:10.2147/OPTH.S235293
   PubMed Web of Science ®Google Scholar
• Hengerer FH, Auffarth GU, Conrad-Hengerer I. iStent inject trabecular micro-bypass with or without cataract surgery yields sustained 5-year glaucoma control. Adv Ther. 2022;39(3):1417–1431. doi:10.1007/s12325-021-02039-4
   PubMed Web of Science ®Google Scholar